Canon Solutions America, Inc., a wholly owned subsidiary of Canon U.S.A., Inc., has announced its support of the 2017 BT5K New York City Run & Walk, held November 12 as part of the American Brain Tumor Association’s (ABTA) signature Breakthrough for Brain Tumors 5K series. Joining esteemed healthcare organizations that included NYU Langone Medical Center and the Healthcare Leaders of New York, Canon Solutions America is pleased to have contributed to ABTA successfully exceeding its fundraising goal of $550,000.
The BT5K Breakthrough for Brain Tumors Run & Walk is the ABTA’s national flagship fundraising event, taking place in cities coast to coast. Currently over 3,840 participants on 293 teams in 9 cities make up the altruistic association that is dedicated to giving back to its communities. Canon Solutions America’s support, along with the help of hundreds of committed sponsors, allows the ABTA to provide vital brain tumor resources to patients and their families, fund promising research studies, and conduct nationwide brain tumor educational programs.
To learn more about the impactful event, watch here.
“We are very appreciative of Canon Solutions America’s support and look forward to working with the organization and its leaders more in the future,” said Kelly Sitkin, chief advancement officer for the ABTA. “The generosity shown by sponsors like Canon Solutions America can help fuel breakthroughs in brain tumor research and help provide support to the thousands of families across the nation affected by brain tumor diagnosis.”
“This event and its resounding impact is further proof of the influence leading organizations—in varied industries—can have on the state of healthcare,” said Tim Gorton, president elect, Healthcare Leaders of New York. “The future of healthcare can be shaped by events like this one and the contributions of organizations willing to be a part of the movement.”
Throughout the BT5K New York City Run & Walk, participants had the privilege to hear from courageous survivors, caregivers, and medical professionals who continue to bring awareness to the ABTA and its great cause. Dr. Andrew Chi, an assistant professor of Neurology at the NYU School of Medicine, and a medical speaker at the BT5K, remarked on the impact of the association: “The ABTA was essential for helping me achieve my goals by providing me with research funding when I was starting my own laboratory, the most critical stage in a medical researcher’s career.”
“Working together with associations like the ABTA and with medical leaders like Dr. Chi are critical elements of Canon Solutions America’s commitment to supporting charitable endeavors that impact lives across America,” said Pete Kowalczuk, executive vice president and general manager, Enterprise Services and Solutions, Canon Solutions America. “We are committed to help support the ABTA’s mission of improving, extending, and, ultimately, saving the lives of those affected by a brain tumor diagnosis.”
For more information on Canon Solutions America, please visit csa.canon.com.
